From the Archives of Internal Medicine:

In women, low to moderate doses of aspirin are associated with significantly lower risk of all-cause mortality, particularly in older women and those with cardiac risk factors. A significant benefit is evident within 5 years for cardiovascular disease, whereas a modest benefit for cancer is not apparent until after 10 years of use.

Inflammation has long been the cause of many life-threatening ailments so the results reaffirm many previous studies where reducing inflammation can extend your life.

Aspirin therapy may influence cardiovascular disease and cancer through its effect on common pathogenic pathways such as inflammation, insulin resistance, oxidative stress, and cyclooxygenase (COX) enzyme activity.

(Source: Long-term Aspirin Use and Mortality in Women)

Technorati: science, longevity, anti-aging, inflammation, cancer, health